secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2021-08-13T23:59:59+00:00
Accession:  0001193125-21-246234
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 9.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics completes de-SPAC merger; starts trading on Nasdaq under TNGX
--------------------------------------------------------------------------------

- Merger closed Aug 10, 2021; Old Tango shares converted at ~0.34 share of new common stock per share.
- PIPE investors purchased 18.61M shares at $10.00/share, raising $186.1M in gross proceeds.
- Post-merger, 87,474,258 shares of common stock outstanding and 9,498,725 shares subject to equity awards.
- Common stock began trading on Nasdaq Capital Market on Aug 11, 2021 under ticker TNGX.
- Directors and officers entered into lock-up agreements for 180 days after closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312521246234/0001193125-21-246234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312521246234/d203347d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-246234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer